We have located links that may give you full text access.
Specific occlusal scheme for partially edentulous patients with TMD signs-preliminary report.
Journal of Stomatology, Oral and Maxillofacial Surgery 2018 April 28
BACKGROUND: The purpose of this study was to ascertain a specific occlusal scheme to reduce temporomandibular disorder signs and symptoms in the therapy of partially edentulous patients with removable partial acrylic dentures.
METHODOLOGY: Thirty-four partially edentulous patients who had unilateral free-end saddle in the mandible along with a history of TMD signs and symptoms were prosthodontically treated, fitting them with new removable acrylic partial dentures (NRAPD) for their lower jaws. The new and specific occlusal scheme was established with tendencies to restrict mandibular functional movements partly; this proved somewhat awkward, but had the benefit of allowing continued unrestricted occlusal contacts in grinding and functional movements. RDC-TMD clinical examinations and answers to questionnaires were provided for the old dentures, and nine weeks after delivery of NRAPD.
RESULTS: After the NRAPD treatment, the patients' painful symptoms were reduced and their mandibular movements were corrected. Statistically significant changes were obtained for the opening pattern (Pearson Chi2 =18.609; P=0001), the maximum unassisted opening (F=3.507; P=0.052), the maximum assisted opening (F=4.299; P=0.042), and the corrected position of midline (F=5.893; P=0.018) before and after the NRAPD treatment. Additionally, significant changes were seen for questions on changes in facial pain to ability to work (Pearson Chi2 =26.921; P=0.00), jaws click or pop when they open, close, or chew (Pearson Chi2 =6.227; P=0.013), jaws make a grating or grinding noise when they open, close, or chew (Pearson Chi2 =9.273; P=0.002), and bites feel unusual (Pearson Chi2 =13.170; P=0.000). Characteristic pain intensity (F=19.311; P=0.000), points for disability score (F=9.830; P=0.003), disability points (F=10.208; P=0.002), and chronic pain grade (F=7.961; P=0.006) were significantly different in terms of the effects of the NRAPD therapy.
CONCLUSION: Specific occlusal scheme in NPARD promoted improvement in the therapy.
METHODOLOGY: Thirty-four partially edentulous patients who had unilateral free-end saddle in the mandible along with a history of TMD signs and symptoms were prosthodontically treated, fitting them with new removable acrylic partial dentures (NRAPD) for their lower jaws. The new and specific occlusal scheme was established with tendencies to restrict mandibular functional movements partly; this proved somewhat awkward, but had the benefit of allowing continued unrestricted occlusal contacts in grinding and functional movements. RDC-TMD clinical examinations and answers to questionnaires were provided for the old dentures, and nine weeks after delivery of NRAPD.
RESULTS: After the NRAPD treatment, the patients' painful symptoms were reduced and their mandibular movements were corrected. Statistically significant changes were obtained for the opening pattern (Pearson Chi2 =18.609; P=0001), the maximum unassisted opening (F=3.507; P=0.052), the maximum assisted opening (F=4.299; P=0.042), and the corrected position of midline (F=5.893; P=0.018) before and after the NRAPD treatment. Additionally, significant changes were seen for questions on changes in facial pain to ability to work (Pearson Chi2 =26.921; P=0.00), jaws click or pop when they open, close, or chew (Pearson Chi2 =6.227; P=0.013), jaws make a grating or grinding noise when they open, close, or chew (Pearson Chi2 =9.273; P=0.002), and bites feel unusual (Pearson Chi2 =13.170; P=0.000). Characteristic pain intensity (F=19.311; P=0.000), points for disability score (F=9.830; P=0.003), disability points (F=10.208; P=0.002), and chronic pain grade (F=7.961; P=0.006) were significantly different in terms of the effects of the NRAPD therapy.
CONCLUSION: Specific occlusal scheme in NPARD promoted improvement in the therapy.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app